首页> 外文期刊>Journal of Korean medical science >Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in Korea.
【24h】

Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in Korea.

机译:在韩国,人类免疫缺陷病毒/结核分枝杆菌共感染患者中耐多药结核的比例。

获取原文
获取原文并翻译 | 示例
           

摘要

Much controversy surrounds the issue of whether HIV infection is a risk factor for developing multidrug-resistant tuberculosis (MDR-TB). In this study, we evaluated the prevalence of and risk factors for MDR-TB in HIV-infected patients at the National Medical Center of Korea. We reviewed the medical records of HIV/TB co-infected patients from January 2005 to May 2011; the drug susceptibility profiles were available for 55 patients. Of these, 32.7% had MDR-TB, which was approximately 3.6 times higher than the prevalence among the general population. Additionally, there were more additional AIDS-defining clinical illnesses in the MDR-TB group than in the non-MDR-TB group (27.8% vs 5.4%, P = 0.032). These results suggest that HIV infection and HIV-related immunosuppresion may contribute to the development of MDR-TB.
机译:HIV感染是否是发展耐多药结核病(MDR-TB)的危险因素这一问题引起了很多争议。在这项研究中,我们在韩国国家医学中心评估了HIV感染患者中MDR-TB的患病率和危险因素。我们回顾了2005年1月至2011年5月的HIV / TB合并感染患者的病历;有55位患者有药物敏感性资料。在这些人群中,有32.7%患有耐多药结核病,大约是普通人群中患病率的3.6倍。另外,耐多药结核病组比非耐多药结核病组还有更多的艾滋病定义临床疾病(27.8%vs 5.4%,P = 0.032)。这些结果表明,HIV感染和HIV相关的免疫抑制可能有助于耐多药结核病的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号